Letter: management of portal vein thromboses in cirrhosis – authors' reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|7|699-699

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.7, 2015-04, pp. : 699-699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: management of portal vein thromboses in cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 698-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: portal vein obstruction – which subset of patients could benefit the most? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 910-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: serum vitamin D levels in primary biliary cirrhosis – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 706-706

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences—Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 543-544

John Wiley & Sons Inc

Access to resources Recommend Favorite